These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 23627250)
1. GMPs and GCPs: a topical comparison. Allen LV Int J Pharm Compd; 2013; 17(1):87. PubMed ID: 23627250 [No Abstract] [Full Text] [Related]
2. GMPs vs GCPs: United States Pharmacopeia General Chapters. Allen LV Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791 [No Abstract] [Full Text] [Related]
7. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
8. Déjà vu all over again! Allen LV Int J Pharm Compd; 2014; 18(3):180. PubMed ID: 25306763 [No Abstract] [Full Text] [Related]
9. From the SNM Committee on Pharmacopeia: Exemption of radiopharmaceuticals from <797>. Hung JC; J Nucl Med; 2004 Oct; 45(10):13N, 16N. PubMed ID: 15551509 [No Abstract] [Full Text] [Related]
10. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]
11. Contemporary pharmaceutical compounding. Allen LV Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042 [No Abstract] [Full Text] [Related]
12. Implementing United States Pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, Part 1. Allen LV Int J Pharm Compd; 2012; 16(2):146-9. PubMed ID: 23050327 [TBL] [Abstract][Full Text] [Related]
13. Implementing United States pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, part 2: documentation and verification. Allen LV Int J Pharm Compd; 2012; 16(3):230-4. PubMed ID: 23050301 [TBL] [Abstract][Full Text] [Related]
14. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4. Allen LV Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315 [TBL] [Abstract][Full Text] [Related]
15. International Conference on Harmonisation; guidance on Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process; availability. Notice. Food and Drug Administration, HHS Fed Regist; 2005 Jun; 70(125):37861-2. PubMed ID: 15988855 [TBL] [Abstract][Full Text] [Related]
16. Standards vs opinions. Allen LV Int J Pharm Compd; 2014; 18(2):92. PubMed ID: 24881110 [No Abstract] [Full Text] [Related]
17. United States Parmacopeia Chapter <797> timeline: 1989 to 2013. Newton DW Int J Pharm Compd; 2013; 17(4):283-8. PubMed ID: 24261142 [TBL] [Abstract][Full Text] [Related]
18. Implementing United States Pharmacopeia Chapter <1163> quality assurance in pharmaceutical compounding, Part 5: Outsourcing and responsible personnel. Allen LV Int J Pharm Compd; 2012; 16(6):490-6. PubMed ID: 23259367 [TBL] [Abstract][Full Text] [Related]
19. Regulators faulted for inadequate compounding pharmacy oversight. Traynor K Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891 [No Abstract] [Full Text] [Related]
20. Quality control analytical methods: strategies to ensure a robust quality-control microbiology program. Griffiths T; Connors A Int J Pharm Compd; 2013; 17(2):130-4. PubMed ID: 23696174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]